OmniAb: A Self-Funding Option Book On 433 Partner Programs

Impact · against what's priced in

OmniAb's transition to self-sustaining cash flow and its vast milestone ledger provide a fundamental floor to the stock, though much of the operational stability is already recognized. The primary upside now depends on the conversion rate of its 433 partner programs into approved drugs through the upcoming clinical readouts.

OABI+0.60: No priced-in read yet
In context: The company is projected to reach break-even for net cash usage in 2026, removing equity dilution risk while maintaining a ledger of $3 billion in potential milestones across 433 programs.
Read from the article alone

OmniAb: A Self-Funding Option Book On 433 Partner Programs

cash flow▲7%
healthcare
biotech
LLY
OABI
clinical trials
pipeline
royalties

Top 1 mover · tap to explore

OmniAb: A Self-Funding Option Book On 433 Partner Programs

What matters in this story

ARDELYX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ARDX

OmniAb: A Self-Funding Option Book On 433 Partner Programs

What matters in this story

ARDELYX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ARDX

How each ticker is affected

Connected tickers

Track these names every morning.

AbbVie: 3 Key Takeaways for Long-Term Investors

After Eli Lilly's Explosive Earnings Report, Is It Too Late to Buy the Stock?

Prediction: $100 per Month Invested in Eli Lilly (LLY) Stock Will Be Worth This Much by 2030

Core Natural Resources: The Buyback Acceleration Is Coming

OmniAb: A Self-Funding Option Book On 433 Partner Programs

What matters in this story

Next reads from the same story arc

ARDELYX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ARDX

OmniAb: A Self-Funding Option Book On 433 Partner Programs

What matters in this story

Next reads from the same story arc

ARDELYX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ARDX

How each ticker is affected

Connected tickers

Track these names every morning.

AbbVie: 3 Key Takeaways for Long-Term Investors

After Eli Lilly's Explosive Earnings Report, Is It Too Late to Buy the Stock?

Prediction: $100 per Month Invested in Eli Lilly (LLY) Stock Will Be Worth This Much by 2030

Core Natural Resources: The Buyback Acceleration Is Coming